The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Pfizer
Research Funding - Daiichi Sankyo (Inst)
Single agent activity of DS-8201a, a HER2-targeting antibody-drug conjugate, in heavily pretreated HER2 expressing solid tumors.
 
Toshihiko Doi
Consulting or Advisory Role - Amgen; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly Japan; MSD; Nippon Boehringer Ingelheim; Novartis
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Sumitomo Group (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Hiroji Iwata
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo
Consulting or Advisory Role - Daiichi Sankyo; Pfizer
Research Funding - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Lilly; MSD; Novartis; Pfizer
 
Junji Tsurutani
Honoraria - AstraZeneca; Chugai Pharma; Eisai; Kyowa Hakko Kirin; Novartis; Taiho Pharmaceutical
Consulting or Advisory Role - Daiichi Sankyo; Lilly; MSD; Novartis; Roche
Research Funding - Daiichi Sankyo; Lilly; MSD; Roche
 
Shunji Takahashi
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Merck Serono; MSD; Novartis; Ono Pharmaceutical; Pfizer; Sanofi; Taiho Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Bayer; Chugai Pharma; Pfizer
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Chugai Pharma; Daiichi Sankyo; Eisai; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
 
Haeseong Park
Research Funding - AstraZeneca (Inst); Bayer (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Gilead Sciences (Inst); Incyte (Inst); Lilly (Inst); MedImmune (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); PsiOxus Therapeutics (Inst); Regeneron (Inst); Roche (Inst); Taiho Pharmaceutical (Inst); Vertex (Inst); Zhejiang Medicine Co., Ltd. (Inst)
Travel, Accommodations, Expenses - Celldex
 
Charles H. Redfern
No Relationships to Disclose
 
Kohei Shitara
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Novartis; Takeda
Consulting or Advisory Role - Bayer (Inst); Chugai Pharma (Inst); Lilly (Inst); Takeda (Inst)
Research Funding - Bayer (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); MSD (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)
 
Chikako Shimizu
Honoraria - AstraZeneca; Chugai Pharma; Eisai
Consulting or Advisory Role - Pfizer
Research Funding - Chugai Pharma (Inst); Lilly (Inst); Pfizer (Inst)
 
Hiroya Taniguchi
Honoraria - Bayer; Chugai Pharma; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Boehringer Ingelheim (Inst); MSD Oncology (Inst); Otsuka (Inst); Takeda (Inst)
 
Tsutomu Iwasa
No Relationships to Disclose
 
Shinichiro Taira
No Relationships to Disclose
 
Albert C. Lockhart
Research Funding - Bayer (Inst); CTI (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Macrogenics (Inst); Millennium (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Teva (Inst); Vertex (Inst); Zenyaku Kogyo (Inst)
 
Jennifer M. Fisher
Employment - Invivoscribe (I)
 
Takahiro Jikoh
Employment - Daiichi Sankyo
 
Yoshihiko Fujisaki
Employment - Daiichi Sankyo
 
Caleb C. Lee
Employment - Daiichi Sankyo
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Daiichi Sankyo; EMD Serono; Janssen
 
Antoine Yver
Employment - AstraZeneca; Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
Kenji Tamura
Research Funding - Daiichi Sankyo (Inst)